You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 6, June 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antiphospholipid Antibodies in Retinal Vascular Occlusions

A Prospective Study of 75 Patients

Agnès Glacet-Bernard, MD; Nazanine Bayani, MD; Pascale Chretien, MD; Catherine Cochard, MD; Françoise Lelong, MD; Gabriel Coscas, MD

Arch Ophthalmol. 1994;112(6):790-795.


Abstract

Objective
To assess the prevalence of antiphospholipid antibodies in patients with occlusive retinal vascular disorders.

Patients
Seventy-five consecutive patients (44 with central retinal vein occlusions, 24 with branch venous occlusions, five with vasculitis plus branch venous occlusion, and two with arterial occlusions) were screened for antiphospholipid antibodies and compared with a control group composed of outpatients with similar systemic vascular disorders.

Results
The antibody assay for one patient was positive for lupus anticoagulant and the antibody assay for three other patients was positive for anticardiolipin antibodies. These four patients had central or branch retinal vein ocelusion and presented with several vascular risk factors. Comparison of the retinal vascular occlusion and the control groups showed no difference in the levels of anticardiolipin antibodies or lupus anticoagulant.

Conclusions
Antiphospholipid antibodies did not seem to be a feature of retinal vein occlusion, but in rare cases (5%) they may contribute to the occlusive phenomenon. A systematic screening does not seem to be justified, but it may be valuable to test for antiphospholipid antibodies in patients without conventional risk factors and in patients with clotting screen abnormalities, particularly if associated with lupuslike syndrome or other elements of the primary antiphospholipid syndrome.



Author Affiliations

From the University Eye Clinic of Créteil (Drs Glacet-Bernard, Cochard, and Coscas), and the Laboratory of Hematology and Immunology, Hôpital Intercommunal (Drs Bayani, Chretien, and Lelong), Créteil, France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Primary Antiphospholipid Syndrome Presenting With a Branch Retinal Artery Occlusion in a 15-Year-Old Boy
Saxonhouse et al.
J Child Neurol 2002;17:392-394.
ABSTRACT  

Case 6-2002- A 54-Year-Old Woman with Left, Then Right, Central-Retinal-Vein Occlusion
Weinstein and Mahmood
NEJM 2002;346:603-610.
FULL TEXT  

Heritable Thrombophilia and Hypofibrinolysis: Possible Causes of Retinal Vein Occlusion
Glueck et al.
Arch Ophthalmol 1999;117:43-49.
ABSTRACT | FULL TEXT  

Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis
Andrews and Hickling
Lupus 1997;6:556-557.
ABSTRACT  

Review : Antiphospholipid antibodies and retinal vascular disease
Dunn et al.
Lupus 1996;5:313-322.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.